The NEUTREXIN brand, founded in 1994 (United States), from 585 sister brands and 17478 competing brands. The NEUTREXIN brand is owned by ASTRAZENECA, a company listed in London. The ISIN, the company's International Securities Identification Number, is GB0009895292. NEUTREXIN belongs to the Drug Manufacturers business sector.